TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/19/24 16:04 | 11/15/24 | CSTL | Castle Biosciences Inc | DE | Health | Health | Medical Laboratories | Stokes Frank | TX | O | CFO | S | -207 | 29.93 | 0 | -7 | -18 | 31 | D | ||||||||||||||
8/13/24 18:13 | 8/7/24 | CSTL | Castle Biosciences Inc | DE | Health | Health | Medical Laboratories | Stokes Frank | TX | O | CFO | S | -257 | 25.70 | 0 | -10 | -24 | 31 | D | ||||||||||||||
12/12/23 19:33 | 12/9/23 | CSTL | Castle Biosciences Inc | DE | Health | Health | Medical Laboratories | Stokes Frank | TX | O | CFO | M.dm | 0 | 0.00 | 0 | 23 | 136 | 40 | D | ||||||||||||||
4/5/23 16:44 | 4/4/23 | CSTL | Castle Biosciences Inc | DE | Health | Health | Medical Laboratories | Stokes Frank | TX | O | CFO | M.d | 14 | 3.38 | 0 | 4 | 21 | 23 | D | ||||||||||||||
12/13/22 16:42 | 12/10/22 | CSTL | Castle Biosciences Inc | DE | Health | Health | Medical Laboratories | Stokes Frank | TX | O | CFO | M.d | 0 | 0.00 | 0 | 8 | 79 | 19 | D | ||||||||||||||
5/16/22 16:18 | 5/12/22 | CSTL | Castle Biosciences Inc | DE | Health | Health | Medical Laboratories | Stokes Frank | TX | O | CFO | M.d | 14 | 3.38 | 0 | 4 | 46 | 13 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |